- Report
- May 2024
- 200 Pages
Global
From €3683EUR$4,150USD£3,182GBP
- Report
- March 2024
- 200 Pages
Global
From €3683EUR$4,150USD£3,182GBP
- Report
- March 2024
- 200 Pages
Global
From €3683EUR$4,150USD£3,182GBP
- Report
- August 2023
- 145 Pages
Global
From €2796EUR$3,150USD£2,415GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3328EUR$3,750USD£2,875GBP
- Report
- July 2024
- 150 Pages
Global
From €3328EUR$3,750USD£2,875GBP
- Report
- July 2024
- 100 Pages
Global
From €3328EUR$3,750USD£2,875GBP
- Report
- January 2022
- 60 Pages
Global
From €3506EUR$3,950USD£3,029GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3106EUR$3,500USD£2,684GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3106EUR$3,500USD£2,684GBP
- Report
- December 2024
- 85 Pages
Spain
From €3106EUR$3,500USD£2,684GBP
- Report
- September 2024
- 80 Pages
Japan
From €3106EUR$3,500USD£2,684GBP
- Report
- September 2024
- 80 Pages
France
From €3106EUR$3,500USD£2,684GBP
- Report
- August 2024
- 80 Pages
Japan
From €3106EUR$3,500USD£2,684GBP
- Report
- June 2024
- 183 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- April 2024
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- April 2024
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- April 2024
- 187 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- October 2023
- 133 Pages
Europe
From €3550EUR$4,000USD£3,067GBP
- Report
- October 2023
- 138 Pages
Asia Pacific
From €3550EUR$4,000USD£3,067GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more